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a b s t r a c t
Invertebrate and vertebrate development relies on complex processes that require many coordinated cell
functions including cell adhesion, migration, proliferation and polarization. These processes depend on
tissues and are spatio-temporally regulated by speciﬁc interactions between cells and between cells and
the extracellular matrices. The dystroglycan, a transmembrane receptor that binds multiple extracellular
matrix proteins, is expressed from oogenesis to organogenesis. There are increasing data suggesting that
the axis, consisting of extracellular component–dystroglycan–cytoplasmic proteins, controls both the
adhesion of cells to matrices as well as the transduction of signals coming from or directed to matrices.
In this article, we review current advances leading to consider that the dystroglycan is a key protein
nestled in an adhesome involved in mechanisms of cell adhesion during embryonic development.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Embryogenesis depends largely on coordinated cell–cell and
cell–extracellular matrix adhesions. For a long time, extracellular
matrices (ECMs) were seen as stable structures to support the
morphogenesis of tissues and organs. It now seems clear that
ECMs are surprisingly dynamic and versatile and that they
inﬂuence, through direct or indirect means, all steps of embryonic
and adult life. ECMs are evolutionarily ancient structures, which
probably appeared when the ﬁrst communities of cells have
emerged (for a review, Adams, 2013). ECMs are composed of
heterogeneous networks of ﬁbrillar and non-ﬁbrillar components
including collagens, laminins, ﬁbronectin, nidogen, elastin, ﬁbri-
lins, tenascin, proteoglycans and non-proteoglycan polysacchar-
ides. These ECM components are secreted and assembled locally
into organized networks that are present in invertebrate and
vertebrate embryos. ECMs are dynamic structures of the cell
environment, whose composition and spatial organization differ
between species, developmental steps and tissues. In most species,
ECM components act as a reservoir and a scaffold for growth
factors, hormones and extracellular miRNAs (Edeleva and
Shcherbata, 2013; Piccinini and Midwood, 2014). They also act to
present growth factors to their receptors, to sense and transduce
mechanical signals (Schiller and Fässler, 2013).
Conventionally, ECMs have been deﬁned as including basement
membranes (basal laminae) and interstitial matrices, which are
less compact and more porous than basement membranes. Inter-
stitial matrices are present between cells, are made by stromal
cells, and are ﬁbrillar. The structure of interstitial matrices
depends on the nature of ﬁbrils, the type and amount of proteo-
glycans. Interstitial matrices are found in loose and dense con-
nective tissues such as cartilage, bone, and embryonic connective
tissues. Basement membranes are sheet-like cell-adherent extra-
cellular matrices that surround or underlie cells, tissues and
organs. They are composed of independent networks of laminins
and collagens that are tethered to nidogens and proteoglycans
(Yurchenco and Patton, 2009). Basement membranes represent
barriers limiting bacterial and viral offensive or inﬁltration of
malignant cells between tissues. Alterations of basement mem-
branes and interstitial matrices deregulate the behavior of cells
and are often responsible for developmental disorders and various
diseases (Lu et al., 2012).
ECMs components bind to cell surface receptors that are mainly
transmembrane glycoproteins connecting them to cytoskeleton net-
works directly to actin or via cytoskeletal linkers. They provide links
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between ECMs and the underlying cytoskeleton leading to solid
anchorages of cells, cytoskeletal rearrangements, co-regulations of
growth factor activities and activations of signal transduction. They
also provide direct or indirect controls of cellular activities such as
adhesion, migration, differentiation, proliferation, and apoptosis.
Furthermore, they are crucial for biochemical signals, which transit
from the cell surface through the cytoplasm to the nucleus to activate
or repress the transcription of genes. In turn, cells could modify and
remodel ECMs by feedback-regulations and thereby control their
extracellular environments. Although researches on the role of ECM
receptors have been mainly focused on the α/β-heterodimeric trans-
membrane integrin proteins, the role of other receptors cannot be
excluded as shown by more and more studies. It is in particular the
case for the dystroglycan (Dg), a cell surface receptor for ECM
components. For several years, various model organisms have been
used to study ECM/Dg interactions in particular during adhesion
processes. These include nematode worm, fruit ﬂy, zebraﬁsh, frog,
chicken and mouse. They all contributed in various ways and
signiﬁcantly to our understanding of the functions of Dg as part of
an adhesome during embryogenesis. This particular structure is a
multi-molecular complex bringing together membrane receptors,
adapter proteins, actin-associated proteins, kinases, phosphatases,
G-proteins, Guanine nucleotide exchange factors (GEFs) and GTPase-
activating proteins (GAPs). An adhesome provides interactive inter-
faces between ECMs, cellular scaffoldings and signaling machineries
(Geiger and Yamada, 2011).
In this review, we will describe the Dg structure and its ligands
and focus on Dg adhesive functions during embryonic develop-
ment using data provided by genetic experiments, gain or loss-of-
function and mutations (Fig. 1). However, the Dg is also involved in
other processes outside of embryonic development, which will not
be discussed here, such as hematopoiesis, virus particle entry
and cancers. The latter are apparently associated with a loss of
Dg affecting both cell adhesion and migration (Sgambato and
Brancaccio, 2005).
Dystroglycan discovery, characterization and ligands
In 1987, biochemical studies from brains of embryonic chickens
had led to the identiﬁcation of a laminin-binding protein with a
molecular mass of 120 kDa, called cranin (or LBP120) (Smalheiser
and Schwartz, 1987). Later, searches for membrane molecules
associated with dystrophin, the cytoskeletal protein that is defec-
tive in Duchenne's muscular dystrophy, resulted in the discovery
of a novel complex of glycoproteins, labeled as the “dystrophin-
glycoprotein complex (DGC)” (Ervasti et al., 1990). Subsequent
cloning of these molecules revealed the complex to consist of
multiple transmembrane molecules. The Dg has been identiﬁed as
a glycan component of the complex and surprisingly, amino acid
sequencing of the puriﬁed cranin demonstrated that it was
identical to the Dg (Gee et al., 1993). Other members of the DGC
include transmembrane proteins, sarcoglycans and sarcospan
(Fig. 2). This complex, in turn, interacts with multiple cytoplasmic
proteins, including dystrobrevin, syntrophin, utrophin, the latter
two linking to F-actin.
The Dg gene is highly conserved between invertebrates and
vertebrates. Protein sequence comparisons reveal that the Dg is a
structurally distinct molecule, which belongs to none of previously
identiﬁed families of cell adhesion molecules. It lacks strong
homology with other proteins, although some similarity has been
noted with immunoglobulin and cadherin-like domains (De Rosa
et al., 2011). The Dg is a large glycoprotein generated by the
translation from a single transcript. The precursor protein is
subject to extensive co- and post-translational modiﬁcation
including proteolysis and extensive glycosylation resulting in two
subunits, α and β, that interact noncovalently (Ibraghimov-
Beskrovnaya et al., 1992). Interestingly, the Caenorhabditis elegans
Dg appears not to be processed into separate α and β subunits
upon maturation (Johnson et al., 2006). Also, the Drosophila Dg is
encoded by a single gene, exists in differentially expressed splice
versions, that lack the mucin-like domain and seems not to be
cleaved (Deng et al., 2003; Schneider and Baumgartner, 2008).
The α-Dg subunit possesses two globular regions separated
by a serine-threonine-rich mucin domain. The globular domains
include potential sites for N-glycosylation, and the mucin region
includes multiple consensus sites for O-linked glycosylation. This
glycosylation is species speciﬁc, developmentally regulated and
tissue speciﬁc leading to molecular mass of α-Dg varying between
120 and 200 kDa. The pattern of glycosylation dictates the speci-
ﬁcity of ligand binding. The glycosylations of a-Dg allow binding to
its ligands in a calcium-dependent manner through their “laminin
G-like” (LG) modules, a protein motif present in many ECM
proteins. The α-Dg has a complex and still not fully characterized
pattern of glycosylation in its central mucin-type domain that is
crucial since aberrant glycosylation of α-Dg is linked to diseases
named dystroglycanopathies and to tumors (Muntoni et al., 2011;
Moore and Winder, 2012). The α-Dg is known to bind laminins,
agrin, neurexins, perlecan, pikachurin and biglycan (Fig. 2A; for a
review: Sciandra et al., 2013). The major extracellular ligands for
the Dg are members of the laminin family, which are major
constituents of ECMs (for a review: Aumailley, 2013).
The β-Dg has a single domain spanning the plasma membrane
and an amino-terminal extracellular domain that binds to the
carboxy-terminal globular domain of α-Dg. The transmembrane
domain of the β-Dg subunit is known to interact with sarcoglycans
(α, β, γ and δ) and sarcospan. Their function is not fully under-
stood. They form a sarcoglycan–sarcospan subcomplex that stabi-
lizes the α-Dg association with β-Dg at the cell surface (for a
review: Marshall et al., 2013). The cytoplasmic tail of β-Dg
interacts with the proteins dystrophin, utrophin, syntrophins and
α-dystrobrevin, thereby to F-actin (for a review: Cohn and
Campbell, 2000). By co-immunoprecipitation and gel overlay
assays, the dystrophin containing the WW domain and two
putative Caþ þ-binding EF-hand motifs were shown to interact
with the β-Dg cytoplasmic domain (Rentschler et al., 1999). Thus,
the Dg-dystrophin and Dg-utrophin complexes form cell adhesion
Fig. 1. The main functions of the dystroglycan adhesome during development. The
components of extracellular matrices bind to α-Dg. This interaction results in the
binding of the intracellular domain of β-Dg to cytoskeleton networks or signaling
components. This consequently leads to several functions for the Dg adhesome
according to species, tissues, organs and stages of embryonic development. EMT:
epithelial-to-mesenchymal transition.
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structures that link ECMs to the F-actin cytoskeleton. In vitro
studies have suggested that the β-Dg interacts with growth factor
receptor bound protein 2 (Grb2), which is an adapter protein,
composed of one Src homology 2 domain (SH2) surrounded by
two Src homology 3 domains (SH3) (Yang et al., 1995). This
association is mediated through β-Dg proline-rich domains and
Grb2 SH3 domains.
ECM–Dg interactions induce phosphorylation of a tyrosine
within the cytoplasmic domain of β-Dg, Tyr 892 in human and
Tyr 890 in mouse. It was shown that the tyrosine kinase involved
Fig. 2. The extracellular and intracellular binding partners of the dystroglycan. (A) Schematic representation of the organization of the α- and β-Dg at the cell membrane
showing topology and major interactions. In the extracellular region, the α-Dg is able to interact with several ligands: laminins, perlecan, agrin, neurexins and pikachurin at
the mucin-like domain, and biglycan in its C-terminal domain. The transmembrane region of β-Dg interacts with the transmembrane proteins sarcoglycans and sarcospan.
The cytoplasmic domain of β-Dg binds to WW domains of cytoplasmic ligands by the PPxY sequence in the C-terminal domain. These ligands are shown in red. The
C-terminal domain of β-Dg interacts with SH2/SH3 domains of proteins that are shown in green. The juxtamembrane cytoplasmic domain binds to proteins (shown in
orange) by the RKKRK sequence. The β-Dg cytoplasmic domain also interacts with F-actin, myosin IIA and plectin (shown in black) in unknown sites. (B–C) The state of
tyrosine phosphorylation regulates the dynamics of Dg. (B) The tyrosine residue 892 is part of PPxY motif that interacts with WW domains of dystrophin or utrophin or the
SH3 domain of Grb2 protein (growth factor receptor-bound protein 2). This motif can be phosphorylated (P) by the tyrosine kinase c-Src. This phosphorylation allows
interaction with the SH2 domain of Grb2, which prevents the interaction of Dg with the cytoskeleton. The phosphorylation of β-Dg helps to modulate its interactions with
cytosolic proteins, functioning as a molecular switch between SH3, WW and SH2 domains, cytoskeletal versus signaling proteins. (C) The Dg is involved in various signaling
pathways controlling cell proliferation, cell migration, differentiation and apoptosis. The Dg is also involved in cell shape. It is able to interact with ezrin and thereby controls
the formation of ﬁlopodia, podosome or actin rich microvilli. (Adapted from Bozzi et al. (2009)).
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in this phosphorylation is the SH2 domain containing protein c-Src
(Sotgia et al., 2001). The Tyr 892 residue is part of the PPxY motif
that interacts with the WW domain of dystrophin/utrophin or
with the SH3 domain of Grb2. Once tyrosine is phosphorylated,
the β-Dg is no longer able to interact with SH3 and WW domains
leading to a loss of interaction with dystrophin/utrophin and thus
with the cytoskeleton. In general, the phosphorylation of β-Dg
helps to regulate its cytoplasmic interactions, functioning as a
balance between interaction with SH3 or WW domains when the
β-Dg is not phosphorylated, and with the SH2 domain when the β-
Dg is phosphorylated (Fig. 2B).
The cytoplasmic domain of β-Dg was also found to interact
with several components of the Extracellular signal-Regulated
Kinase/Mitogen-Activated Protein Kinase (ERK-MAP) cascade and
indirectly with the Focal-Adhesion Kinase (FAK) (Yang et al., 1995;
Spence et al., 2004a). The cytoplasmic domain of β-Dg also binds
to different ligands according to species, stages of development,
tissues and organs. It interacts with caveolin-3, a muscle-integral
membrane protein of the sarcolemma; with rapsyn, a protein
located at the post-synaptic membrane in neuromuscular junc-
tions; with dynamin, a GTPase implicated in endocytosis. It also
interacts with plectin, a widely expressed cytolinker protein at Z-
disks and the sarcolemma, where it acts as a mediator of desmin
intermediate ﬁlament anchorage (Sotgia et al., 2000; Bartoli et al.,
2001; Zhan et al., 2005; Rezniczek et al., 2007). Finally, the Dg
binds to the cytoskeletal adapter protein ezrin (Fig. 2C; Spence
et al., 2004b) and forms a complex with a Rho-speciﬁc guanine
nucleotide exchange factor (Dbl). The complex is targeted to the
membrane by the Dg where it drives the local activation of the cell
division control protein 42 (Cdc42) and the formation of ﬁlopodia
(Batchelor et al., 2007).
Thus, all these data suggest that the glycosylation of α-Dg is
crucial for its link to laminin and that the phosphorylation of β-Dg
on tyrosine regulates its association with intracellular binding
partners. These interactions between ECM components, the Dg
and cytoplasmic proteins (Table 1) may be of biological impor-
tance in transducing signals arising from the binding of Dg to ECM
proteins or in transferring information between the Dg complex
and several signaling pathways that control mechanisms of adhe-
sion during embryonic development.
Dystroglycan expression
In humans, Dg transcripts were detected in cardiac and skeletal
muscles, brain, kidney, liver, lung, diaphragm, placenta, pancreas
and stomach (Ibraghimov-Beskrovnaya et al., 1992). The highest
level of expression is in heart and skeletal muscles. In adult mice,
the Dg exhibits essentially the same expression proﬁle, i.e. in
skeletal muscles, gastrointestinal tract (salivary glands, pancreas,
intestine, liver), trachea, kidney, mammary gland, testis and the
uterus (Durbeej et al., 1998). In early mouse development (E5-E6),
transcripts are detected in cells around the Reichert's membrane,
which is a thick basement membrane between the parietal
endoderm and the trophectoderm (Williamson et al., 1997). Later
during development, the protein expression correlates with base-
ment membranes of notochord, neural tube, myotomes, myocar-
dium, spinal cord, lung buds, sex cords, promesonephros,
mesonephric duct and tubules (Anderson et al., 2007). In Xenopus
laevis, Dg-maternal mRNAs are detected from the 4-cell stage.
Then, they are detected throughout the development of embryos
in different tissues. The protein is present in notochord cells and
Table 1
The dystroglycan and its associated proteins.
Dystroglycan Ligands Sites of interaction Roles References
Agrin O-mannosylglycan protruding from
the mucin-like region
Aggregation of acetylcholine receptors
on skeletal muscle ﬁbers
Gee et al. (1994)
α-Dystroglycan Biglycan The protein core of the COOH-terminal
third of α-dystroglycan
Muscle integrity, and synapse stability at the
neuromuscular junction
Bowe et al. (2000)
Laminins O-mannosylglycan protruding from the
mucin-like region
Connect laminin to actin Ervasti and Campbell
(1993)
Neurexins O-mannosylglycan protruding from the
mucin-like region
Intercellular adhesion of brain cells Sugita et al. (2001)
Perlecan Mucin-like region Integrity of ECMs Costell et al. (1999)
Pikachurin O-mannosylglycan protruding from the
mucin-like region
Connection between retinal photoreceptors
and bipolar cells
Sato et al. (2008)
β-Dystroglycan Caveolin-3 Phosphorylated Y in the C-terminal WW
domain binding motif: PPxY892
Regulation of membrane cytoskeletal
connections
Sotgia et al. (2000)
Dystrophin/
utrophin
Non- phosphorylated Y in the C-terminal
WW domain binding motif: PPxY892
Regulation of membrane cytoskeletal
connections
James et al. (2000)
ERK-MAP The juxtamembrane portion of the
cytoplasmic domain
Signaling Ferletta et al. (2003)
Ezrin The juxtamembrane portion of the
cytoplasmic domain RKKRK
Regulation and organization of the actin
cytoskeleton and cellular morphology.
Spence et al. (2004b)
F-actin Cytoplasmic tail Organization of the actin cytoskeleton in ﬁbroblasts Chen et al. (2003)
Grb2 The C-terminal SH3 binding domain: PxxP Signal transduction and cytoskeleton
organization
Yang et al. (1995)
Myosin IIA Cytoplasmic tail Organization of the actin cytoskeleton
in notochord cells
Buisson et al. (in
preparation)
Plectin The C-terminal binding domain Desmin intermediate ﬁlament anchorage
at the sarcolemma
Rezniczek et al.
(2007)
Rapsyn The juxtamembrane portion of the
cytoplasmic domain RKKRK
Clustering acetylcholine receptors during
neuromuscular synapse formation
Cartaud et al. (1998)
Src family
kinases
Phosphorylated Y in the C-terminal WW domain
binding motif: PPxY892
Regulation of podosome formation in
myoblasts.
Thompson et al.
(2008)
Vinexin The C-terminal SH3 binding domain: PxxP Cell adhesion and spreading. Thompson et al.
(2010)
ERK: extracellular signal-regulated kinase; Grb2: growth factor receptor-bound protein 2.
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remains expressed throughout its differentiation processes. It is
also present in cells of hypochord, brain, otic vesicles, eyes, visceral
arches, somites, pronephros and pronephric canal, skin and heart
(Lunardi and Dente, 2002; Moreau et al., 2003). In Danio rerio, Dg-
maternal mRNAs are detected at the 128-cell stage, before the
onset of zygotic transcription and ubiquitously expressed through-
out gastrulation. By the tailbud stage, transcripts are present in
adaxial cells, the developing neural tube, throughout the paraxial
mesoderm, in the notochord and hypochord (Parsons et al., 2002).
During Drosophila development, the Dg is expressed in oocytes, at
the basal side of follicular epithelium, in imaginal discs of wings,
on muscle, glia, neurons and also on the apical surface of photo-
receptor cells (Schneider et al., 2006). In Caenorhabditis elegans,
the Dg is not expressed in muscle but in gonads, epithelial cells
and neurons (Johnson et al., 2006).
The ubiquitous expression of Dg in all these species and in a
variety of cell types from early development to adulthood indi-
cates that it might have critical roles in a variety of processes
essential to organ formation and where cell adhesions with ECMs
are required.
Dystroglycan promotes cell polarity during oogenesis
During Drosophila melanogaster oogenesis, the establishment of
the anteroposterior polarity in oocyte is essential for the establish-
ment of the anteroposterior axis of the future embryo. This process
involves cytoskeletal rearrangements that translocate the
microtubule-organizing center from the anterior region of early
oocyte to the posterior region of developing oocyte (for a review:
Riechmann and Ephrussi, 2001). Then, following a signal from
posterior follicle cells, the posterior microtubule-organizing center
disappears and a new one forms in the anterior pole of oocyte.
Clonal analyses of homozygous Dg mutation in the germline show
the lack of actin enrichment at the oocyte cortex and the lack of
displacement of the microtubule organizing center to the posterior
region of oocyte. This results in the loss of the early polarization of
oocyte (Deng et al., 2003).
The Dg function has also been investigated in the ovarian
follicular epithelium. This epithelium renews constantly from
two somatic stem cells per ovariole. These stem cells give rise to
follicle cells that proliferate and form through a mesenchymal–
epithelial transition a columnar epithelium over the growing
oocyte. In the epithelium, follicle cells are in contact with a
basement membrane and with germline cells leading to distinct
basal, apical and lateral cell-membrane domains. Each domain
accumulates speciﬁc protein complexes that are actively involved
in the cell-membrane polarity. The Dg is localized at basal-cellular
domains of plasma membranes, where it interacts with perlecan, a
large multidomain heparan sulfate proteoglycan of the ECMs. The
Dg function in follicle cells has been studied with lethal Dg alleles
that have been generated by the excision of a P-element inserted
into the ﬁrst non-coding exon of Dg to produce deletions around
the Dg promoter (Deng et al., 2003). Inactivation of the gene
encoding Dg causes loss of lateral cell markers and an expansion of
apical markers to the basal pole of follicle cells. Overexpression of
Dg results in a reduced apical localization of these markers.
Mutant cells lose their epithelial shape, form multiple layers and
often die (Deng et al., 2003). Interestingly, clonal analyses of Dg
mutant follicle cells, which allow comparing wild-type and mutant
cells in the same tissue, show an abnormal orientation of basal
actin ﬁbers in adjacent non-mutant follicle cells as well as
disruption of its laminin network. Basal-actin ﬁbers lose their
orientation at a direction perpendicular to the anteroposterior axis
of the egg chamber. This suggests that the Dg has a non-cell-
autonomous effect on the planar polarity of the basal actin in
follicle cells that is to say that the Dg directs the orientation of
laminin networks that transmit information into a neighboring
cell to coordinate the orientation of actin ﬁbers (Deng et al., 2003).
Interestingly, when follicle cells lack perlecan, they develop
polarity defects similar to those of Dg mutant cells (Schneider
et al., 2006). These data suggest that the perlecan and the Dg
provide a basal ‘polarizing cue’ required for differentiation of basal
membranes and maintenance of epithelial cell polarity in follicle
cells (Schneider et al., 2006). Therefore, it has been proposed that
the binding of perlecan to the Dg, stabilizes the Dg in basal
membranes and that the Dg is required for stabilizing speciﬁc
protein complexes at lateral membranes, which in turn prevents
apical components from invading basolateral-membrane domains
(Schneider et al., 2006). Today, these conclusions seem to be
questioned as a result of the discovery of Dg nonsense mutations
that are homozygous viable and fertile (Christoforou et al., 2008).
The effects of these null mutations on cell polarity in the ovary
have been studied (Mirouse et al., 2009). They show that apical,
lateral, and basal plasma membrane domains of follicle cells form
normally but cells lose the planar polarity of their basal actin
stress ﬁbers. The oocyte grows in all directions and exhibits a
short, round-egg phenotype (Mirouse et al., 2009).
The differences in results provided by these studies could be
explained by the fact that studies of Deng et al. (2003) use
deletions in the Dg locus that also remove the mRpL34 gene that
encodes a mitochondrial ribosomal protein (mRpL34 gene),
whereas studies of Mirouse et al. (2009) use null alleles of Dg. It
is interesting to note that phenotypes obtained by Dg-deletion
alleles can be rescued by transgenes expressing either mRpL34 or
Dg proteins suggesting that the loss of both genes causes polarity
defects (Mirouse et al., 2009). This also suggests that the energetic
stress caused by disruption of mRpL34 can explain by itself the
epithelial polarity phenotypes of Dg-deletion alleles. Surprisingly,
an identical polarity phenotype, to those observed for Dg-deletion
alleles, is obtained when ﬂies carrying nonsense alleles of Dg are
cultured on food without glucose (Mirouse et al., 2009). Thus, it
has been proposed that the polarity phenotype observed, under
normal conditions with Dg-deletion alleles, results from the loss of
mRpL34 proteins that disrupts mitochondrial function leading to
reduce cellular energy. Consequently, the Dg seems to be required
for follicle-cell polarity only under conditions of energetic stress
(Mirouse et al., 2009). Furthermore, it has been shown that a null
mutant of the Drosophila homolog of dystrophin has no conse-
quence on follicle cell epithelialisation under low-energy condi-
tions, that the Dg that lacks the SH3-binding domain disrupts
follicle-cell polarity and that the Dg with a mutated dystrophin-
binding site does not (Deng et al., 2003; Yatsenko et al., 2007).
Thus, from all these data, it seems likely that interaction between
the Dg and its ligand perlecan controls epithelial polarity under
low-energy conditions by signaling through the SH3-binding
domain. These results should be interpreted with caution because
Haack et al. (2013) have nicely showed that the phenotype of Dg
mutants resulted of an artefact due to the increased damage
caused by dissecting ovaries of starved ﬂies. They suggest that
the Dg is not required for apical–basal polarity under starvation
conditions in the follicle-cell epithelium. Further investigations
will be required to understand the exact molecular mechanisms
underlying the role of Dg in germline and follicle-cell polarization
due to the signaling cascade it activates in these processes.
Dystroglycan promotes basement membrane assembly
in early development
During early development, basement membranes appear gen-
erally beneath cells that secrete their components, but in some
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cases, they are assembled on cell surfaces that do not synthetize
basement membrane proteins. These two points argue that
assembly of proteins in basement membranes might be mediated
by cell-surface receptors. As Dg is a receptor of laminins, a main
component of basement membranes, efforts have been devoted to
determine if it initiates and promotes the matrix assembly.
In 1997, the knockout of Dg in mice showed that the Dg
depletion is lethal for mice embryos, which die at embryonic
day 6.5 because of the disorganization of Reichert's membrane, a
specialized basement membrane appearing around the implanta-
tion of embryos that lies between parietal endoderm and tropho-
blast cells (Williamson et al., 1997). The Dg depletion causes a
patchy distribution of laminin and collagen instead of a continuous
layer, in addition embryos showed gastrulation and mesoderm
defects. The authors have concluded that the Dg may be necessary
for the assembly of ECM proteins that comprise Reichert's mem-
brane. Interestingly, mouse embryos that lack the laminin γ1 chain
did not survive beyond day 5.5. Basement membranes did not
develop and primitive endoderm cells remained in the inner cell
mass (Smyth et al., 1999). On the other hand, crucial events of the
basement membrane formation during early gastrulation in mice
can be recapitulated using embryoid bodies (EBs). EBs arise from
suspended aggregates of mouse embryonic stem cells. Following
two days of culture, EBs provide an in vitro model of blastocyst
development in which the inner cell mass differentiates to form
visceral endoderm, basement membrane, polarized epiblast and
proamniotic-like cavity. The endoderm synthesizes and secretes
laminins and most of the type IV collagen. The basement mem-
brane in turn is required for polarization of the epiblast and
cavitation. In 1998, using the strategy of Dg-null EBs, it was
demonstrated that the Dg is crucial to bind soluble laminins, to
organize it at cell surfaces which constitutes the initial step in the
formation of a basement membrane (Henry and Campbell, 1998).
Later, it has been shown that EBs, formed from laminin-null or
integrin-null embryonic stem cells, were unable to form a base-
ment membrane, to convert the inner cell mass into polarized
epiblast and to form a proamniotic cavity (Li et al., 2002).
Conversely, when the Dg lacks in EBs, a basement membrane
forms followed by epiblast differentiation and cavitation. This
result is corroborated by a study on zebraﬁsh embryos using
antisense-morpholino oligonucleotides to inhibit the expression
of Dg (Parsons et al., 2002). The loss of Dg expression is not lethal
and laminin-matrix assembly is not affected during early devel-
opment suggesting that the Dg is dispensable for basement
membrane formation.
Other studies performed in vitro have implicated the Dg in
basement membrane assembly. In cultures of muscle cells derived
from Xenopus embryos, clusters of Dg are induced by laminin–
laminin binding (Cohen et al., 1997). In cultures of C2C12 myo-
blasts, the COOH-terminal long arm of laminin mediates receptor
binding that facilitates interactions between the three NH2-term-
inal short arms leading to the basement membrane assembly
(Colognato et al., 1999). Also, the binding of the α-Dg subunit to
laminin is a crucial step in the formation of laminin matrices of
embryonic-stem cells, in deposition of laminin on the surface of
Schwann cells, and in polymerization of laminin in mammary
epithelial cells (Tsiper and Yurchenco, 2002; Weir et al., 2006).
Interestingly, in vitro molecular genetic analyses in mammary
epithelial cells and in vivo in Xenopus kidney, skin and notochord
have demonstrated that the Dg can mediate laminin deposition
(Weir et al., 2006; Bello et al., 2008; Sirour et al., 2011; Buisson
et al., in preparation).
Both the genetic and the EBs data reveal that the Dg is not
generally essential for basement membrane assembly and that its
genetic loss does not result in the disruption of most basement
membranes. Thus, it is conceivable that the involvement of Dg in
the formation of basement membranes may vary depending on
species, cell types, embryonic regions and/or states of embryonic
development. Early in development, the Dg is required for the
formation of the extra-embryonic basement membrane (Reichert's
membrane) but not for the embryonic basement membrane
adjacent to epiblast later in development. It is conceivable that
deposition and/or formation of laminin matrices is regulated by
synergistic function of Dg, integrins and syndecans, and that other
matrix components stabilize laminin incorporation into ECMs. It is
also conceivable that differences between early and late require-
ments for Dg in basement-membrane formation may be explained
by the action of other laminin receptors differentially expressed in
the space, time and tissues during embryonic development.
However, most data support a model whereby the Dg ensures
the initial binding of laminin to cell surfaces, whereas integrins
and perlecan are required for the assembly of laminin into
matrices after its binding to cells. Thus, the Dg plays a key
role in nucleating the assembly of a primary laminin matrix,
which then will serve as scaffolding for the assembly of other
components of embryonic-basal membranes. Following matrix
assembly on the cell surface, the laminin/Dg interaction is required
to promote cell adhesion mechanisms involved later during
development.
Gastrulation requires the disengagement of the dystroglycan
adhesome
In birds and mammals, at the level of the primitive streak, a
transient embryonic structure where gastrulation takes place, the
epithelial-to-mesenchymal transition (EMT) generates the meso-
derm layer. EMT is a multistep process in which cells change their
epithelial shape to adopt an invasive-mesenchymal phenotype. It
includes local loss of cell polarity, tight junctions, disruption of
ECM, which favours the ingression of cells. Using gastrulation of
chick embryos as a model of EMT, it has been shown that integrins
and the Dg are two major groups of basal membrane proteins
involved in epiblast-cell adhesion to ECMs. The Dg gene expres-
sion is restricted to the epiblast during early development and the
protein is localized to basolateral membranes (Nakaya et al., 2011).
In epiblast cells, the Dg mediates adhesive links between
intracellular-cortical microtubules and ECMs, by interaction of its
β-subunit with the cortical CLIP-associated protein (CLASP), a
microtubule plus-end tracking protein (Nakaya et al., 2013). The
adhesome ECM/Dg/CLASP/microtubules maintains interactions
between epiblast cells and ECMs, thereby their polarity. The
disruption of microtubules and the expression of CLASP mutants
lead to the loss of Dg at cell surfaces in front of the ECM and of
epiblast-cell adhesion to the ECM. It was shown that the removal
of Dg from the complex promotes ECM breakdown and thus cells
are able to initiate their EMT (Nakaya et al., 2013). These data
suggest that the disengagement of this complex promotes ECM
breakdown, thereby promoting the loss of adhesion to the matrix
and therefore the ingression of cells during gastrulation. They also
suggest that the stability of the adhesome ECM/Dg/CLASP/micro-
tubules promotes cell adhesion to ECMs and cell epithelialization.
Dystroglycan controls cell epithelialization
During morphogenesis, epithelia undergo rearrangements in
response to extracellular signals. This requires the coordinated
regulation of cell–cell and cell–matrix adhesion. This last broadly
relies on integrin-mediated cell-matrix adhesion on the basal side of
cells. However, there are more and more data to suggest the
involvement of Dg in these processes. In mouse, the Dg is enriched
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towards the basal side of epithelial cells that are in close contact with
ECM in developing and adult tissues, such as kidney, liver, intestine,
trachea, salivary gland and skin (Ibraghimov-Beskrovnaya et al., 1993;
Durbeej et al., 1998). Most studies, to address its role, were
performed in vitro using organotypic cultures and blocking antibo-
dies against the Dg or laminins. They suggest a key role of Dg in
promoting the cell adhesion for epithelialization, survival and
differentiation of many tissues. It is necessary for the cell adhesion
during branching of tubular epithelia as lung, and salivary glands
(Streuli, 1999). Also, it is required for the cell adhesion leading to the
differentiation of mammary gland cells, pancreas β-cells, thymocytes
and oligodendrocytes (Jiang et al., 2001; Galvin et al., 2010; Liou et al.,
2010).
In the skin of Xenopus laevis, the Dg is expressed in the more
internal sensorial layer. In vivo, morpholino knockdowns of Dg
affect cell–cell adhesion, as shown by the reduction of E-cadherin
expression at intercellular contacts. The depletion of Dg also
affects the laminin deposition, the ECM organization and the
intercalation of multiciliated cells suggesting a non-autonomous
role in skin epithelialization (Sirour et al., 2011).
The notochord, a tubular epithelial tissue, develops from the
mesoderm during gastrulation in the midline of embryos. Its
formation required the segregation from paraxial-mesodermal
cells, the mediolateral intercalation of cells, the secretion of an
ECM and the differentiation of a vacuole. Interestingly, the Dg
expression in notochord is dynamic during early development, to
the end of gastrulation and during neurulation (Moreau et al.,
2003). This expression coincides with the segregation and ante-
roposterior differentiation of the notochord. Dg-depleted cells are
properly speciﬁed, exhibit defects in ECM formation, intercellular
adhesion and cell polarity, leading to defects in morphogenesis
and differentiation. Data show that the Dg is required for the
notochord ECM assembly, the notochord-cell recruitment within
the tissue and the mediolateral-cell intercalation. Moreover, myo-
sin IIA was identiﬁed as a new Dg ligand in notochord cells. In
particular, the laminin-Dg-myosin IIA adhesome is involved in
maintaining cytoskeleton integrity and polarity during the differ-
entiation of cells, i.e. the formation of vacuoles (Buisson et al., in
preparation).
Dystroglycan as an adhesion receptor during myogenesis
In human, the importance of Dg for adult muscle function is
well established, in particular due to severe phenotypes of
muscular dystrophies (Carmignac and Durbeej, 2012). Muscular
dystrophies comprise a heterogeneous group of disorders that
produce progressive skeletal muscle weakness and wasting in
patients with mutations disrupting the adhesion of muscle cells to
ECMs. The Dg is a component of the dystrophin-glycoprotein
complex in muscle, where it constitutes a key element to anchor
the ECM to intracellular actin ﬁlaments. The lack or mutation of
one or more components of this complex results in debilitating
muscular and neuromuscular diseases (Barresi and Campbell,
2006). The Dg thus ensures the structural stability of the muscle
cell membrane, thereby protecting muscle cells against membrane
damage induced by muscle contractions and relaxations. While
the role of Dg is well established in adult muscles, it remains
poorly understood in early muscle development.
In mouse embryos, the Dg is expressed in somites during their
differentiation. It colocalizes with components of ECMs around
somites (Anderson et al., 2007). During the segregation of myo-
tomes, the Dg is uniformly distributed at the surface of myotomal
cells that express Myf5, a transcription factor of the family of
Myogenic Regulatory Factors (MRF), as well as in migratory
myoblasts (Anderson et al., 2007). Consequently, the Dg could
play a role in myoblast adhesion and migration. However, this
possibility is difﬁcult to analyze during myogenesis because of the
early embryonic lethality of mice lacking the Dg (Williamson et al.,
1997). Furthermore, in chimeric mice with Dg deﬁciency in
skeletal muscles, or in mice with a knockout of Dg in myoblasts,
both adhesion and migration seem to be unaffected during early
development. Also, the deposition of laminin and the formation of
basement membranes appear unaffected in muscles (Cohn et al.,
2002; Côté et al., 1999). The latter reinforces the view that the Dg
is necessary for some but not all basement membrane formation
during embryonic development.
Interestingly, in vitro, it has been demonstrated that the Dg is a
component of myoblast podosome, an actin-rich structure sur-
rounded by adhesion and scaffolding proteins (Thompson et al.,
2008). By immunoprecipitation, GST-pulldown and immunoﬂuor-
escence, a complex comprising Dg, Src and Tks5 has been
identiﬁed in podosomes. The adapter protein Tks5 is a scaffolding
protein containing ﬁve SH3 domains known to be required for
podosome formation. The Dg overexpression and mutation of the
Dg tyrosine 890 (tyrosine 892 in human) led to propose that Src-
dependent phosphorylation of Dg results in the formation of a Dg/
Src complex that drives the interaction between the Dg and Tks5.
In turn, this complex regulates the podosome formation in
myoblasts (Thompson et al., 2008). Furthermore, decreasing levels
of Dg by RNAi knockdown increased myoblast adhesion and
spreading on ﬁbronectin substrates, whereas overexpressing Dg
reduced adhesion and spreading (Thompson et al., 2010). Thus, it
seems that the ECM/Dg/Src/Tks5 adhesome actively regulates
myoblast behaviors. It remains to show whether or not this is
the same in adhesion and migration mechanisms that govern
myogenesis in vivo. A possible answer comes from studies in
Xenopus.
In Xenopus embryos, the Dg is expressed at the border between
somites and the notochord, as well as at intersomitic junctions.
The Dg depletion by morpholinos or overexpression of a Dg
deleted of its cytoplasmic domain has highlighted its fundamental
role during somitogenesis (Hidalgo et al., 2009). In these contexts,
the Dg disruption results in normal segmentation of the presomi-
tic mesoderm but affects the number, the size, and the integrity of
somites. The adhesion of myoblasts to ECMs, required for their
alignment in somites, is also affected without disrupting the
expression of differentiation markers MyoD and MRF4. Thus, the
results show that laminin/Dg interactions are necessary for myo-
blast adhesion required to form myotome ﬁbers in parallel align-
ment with the notochord. In zebraﬁsh, the knockdown of Dg by
antisense morpholinos leads to disorganized muscles and apopto-
tic as well as necrotic cells (Parsons et al., 2002). In a forward
genetic approach, a zebraﬁsh mutant (patchytail) has been identi-
ﬁed (Gupta et al., 2011). It corresponds to a point mutation
identiﬁed in the Dg gene that results in a missense amino acid
change of valine to aspartic acid. This change is present in the
C-terminal domain of α-Dg leading to reduce transcripts and to
the complete absence of Dg. Mutants show that the Dg is
dispensable for the basement-membrane formation during early
zebraﬁsh development. At later stages, however, the loss of Dg
leads to impaired locomotion and dystrophic muscles due to
extensive tearing of ECMs at the myosepta, thus destabilizing
myoﬁber attachments at somite boundaries. These data suggest
that the zebraﬁsh-Dg adhesome seems to be required for long-
term survival of muscle cells, but is dispensable for muscle
formation during early embryonic development (Gupta et al.,
2011). Again, this suggests that the Dg-adhesome function may
be species and tissue speciﬁc.
The Dg is also important for the development and function of
myotendinous junctions (MTJs). MTJs are highly specialized and
architecturally complex structures at the interface between muscle
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and tendon. The development of MTJs is a complex process
involving cell–ECM interactions as well as cell–cell interactions
between muscle and tendon. An important ﬁrst step is the
deposition of a basement membrane at the interface between
tendon and muscle cells. Much of our knowledge of this process
comes from studies in Drosophila. In this model, tendon cells
connect muscle cells to the chitinous exoskeleton and are similar
to tendon cells that link muscles of vertebrates to bone. At the
interface between tendon and muscle cells, precise spatiotemporal
expressions of Dg are required for the MTJ formation. At earlier
stages, the Dg is ﬁrst uniformly present at epidermal cell surfaces
then according to a striped pattern. It is excluded from epidermal
cells that will give rise to tendon cells. Then, the Dg is enriched at
the termini of growing muscles facing the tendon matrix empha-
sizing its role as an adhesive molecule (Schneider and
Baumgartner, 2008). When the Dg is abnormally expressed in
tendon cells, the composition of the tendon matrix is affected,
resulting in aberrant muscle attachments and embryonic death
(Yatsenko and Shcherbata, 2014). Interestingly, the dynamic
expression of Dg is posttranscriptionally regulated by miRNA. Both
the miRNA (miR-9a) and the Dg have expression patterns that are
mutually exclusive. The Dg is present in ectodermal cells, while
tendon cells express the miR-9a (Yatsenko and Shcherbata, 2014).
Upon miR-9a deﬁciency, the Dg is detected not only in muscles but
also on the membrane of tendon cells. This expression of Dg in
tendon results in alteration of contacts between muscle and
tendon cells and disorganization of musculature assembly
(Yatsenko and Shcherbata, 2014). These data suggest that the Dg
adhesome is required at the MTJ and that the miR-9a acts as a
factor that regulates the expression of Dg in tendon cells, and
thereby the function of the adhesome.
The functions of dystroglycan during neurogenesis
In mouse, the Dg is expressed in the ﬂoor plate of the neural
tube and in cells facing the basement membrane delineating the
neuroepithelium of forebrain and hindbrain. It is also expressed at
the level of spinal cord, otic and optic vesicles. Interestingly, the Dg
is also found in motoneuron axons suggesting that it plays a role in
cell adhesions required for the axonal guidance and growth
(Anderson et al., 2007). This hypothesis is consistent with work
done in Caenorhabditis elegans, where a mutation in the gene,
which leads to depletion of Dg, causes defects in guiding the
growth of neurons (Johnson et al., 2006). It is also consistent with
new ﬁndings on the developing nervous system of mice and in
particular on the axonal guidance that requires precise patterning
of guidance cues (Wright et al., 2012). These cues include mem-
bers of the Slit, Netrin, Semaphorin, and Ephrin families of ligands.
They function as attractants or repellants by binding to cell-surface
receptors that transduce guidance informations through signaling
cascades that reorganize the cytoskeleton within growth cones of
axons (for a review, Vitriol and Zheng, 2012). Mice, in which the
Dg was deleted from the epiblast to circumvent the early embryo-
nic lethality, have been generated (Wright et al., 2012). Using this
model, it was found that the Dg is required for the development of
major axonal tracts that grow along basement membranes of
spinal cord ventrolateral funiculus, dorsal funiculus, and descend-
ing hindbrain projections. It was also found that the Dg binds
directly to the laminin G domain of Slit leading to organize its
distribution in both the basement membrane and the ﬂoor plate of
spinal cord in vivo (Wright et al., 2012). Therefore, it can be
proposed that Dg functions in an adhesome that controls axon
guidance by organizing the availability of axonal tracts and
guidance cues.
During mouse brain development, the precise synapse forma-
tion is crucial for the central nervous system to function normally.
It requires the precise adhesion, migration and targeting of axons,
the apposition of presynaptic and postsynaptic termini and ﬁnally
the proper differentiation and maturation of neurons and synaptic
termini. The Dg was found in neurons of the cerebral cortex,
hippocampus, olfactory bulb, basal ganglia, thalamus, hypothala-
mus, brainstem and cerebellum. Electron microscopy revealed that
the Dg was preferentially associated with postsynaptic specializa-
tions. The Dg was also detected in astrocytes around vessels, in
those facing the pia mater and in endothelial cells at the blood–
brain barrier (Zaccaria et al., 2001). Laminin, agrin, and perlecan
are not abundant in brain except in the perivascular space in
contact with astrocytes but not with neurons. The Dg has been
identiﬁed as a receptor for neurexins, speciﬁc proteins of the
neuron-speciﬁc cell surface proteins (Sugita et al., 2001).
The works of Anderson et al. (2007) have demonstrated the
expression of Dg in the brain neuroepithelium of embryos at the
level of cell contacts with the basal lamina surrounding optic
vesicles and neural tube. The depletion of Dg speciﬁcally in the
central nervous system of mice with the Cre-loxP system, results
in brain malformations similar to human syndromes associated
with defects such as dystrophy syndromes (Moore et al., 2002).
The Dg-null brain phenotypes include a fusion of left and right
hemispheres and cerebellar folia, a training defect of the different
cortical layers and aberrant migration of granule cells (Moore
et al., 2002). The brain-speciﬁc knockout of Dg shows disconti-
nuities in the pial surface basal lamina (glia limitans) and cortical
neuron migration defects (Moore et al., 2002; Michele and
Campbell, 2003). Moreover, the brain-speciﬁc deletion of Dg
shows distinct functions for neuronal and glial Dg. Neuronal Dg
plays a role in synaptic plasticity and glial Dg is involved in
adhesion processes during forebrain development. Speciﬁc differ-
ences in the Dg glycosylation in these cells may modulate the
diversity of its ligands and binding afﬁnities leading to the
diversity of Dg adhesive functions in the brain (Satz et al., 2010).
All these studies show that the Dg has an important role in the
formation of the central nervous system and especially on cell
adhesion required for growth and guidance of neurons during
embryonic development.
The vertebrate retina is part of the central nervous system. In
retina, photoreceptors form specialized synapses with bipolar and
horizontal cells, the ribbon synapse. In mouse, a novel protein of
the retinal ECM, pikachurin, has been identiﬁed, and observed in
the synaptic cleft of the ribbon synapse (Sato et al., 2008). The
pikachurin is expressed in photoreceptors of the neuroblast layer
at mouse embryonic day 14.5, which corresponds to early cone
and rod development. In the adult retina, the pikachurin is
restricted to the synaptic cleft of the ribbon synapse, near the
postsynaptic termini of bipolar cells and colocalized with both the
dystrophin and Dg. The pikachurin contains domains similar to the
laminin G-like domains known to interact with Dg. Immunohis-
tochemistry and pull-down assay have established that the pika-
churin is a novel ligand of α-Dg (Sato et al., 2008; Kanagawa et al.,
2010). In order to investigate its biological functions, a pikachurin-
knockout mouse was generated. Whereas dendrites of horizontal
cells in the ribbon synapses were normal, dendrites of both rod
and cone photoreceptors were absent in these mice affecting
synaptic signal transmission and both the timing and the ampli-
tude of the bipolar cell response to scotopic and photopic condi-
tions (Sato et al., 2008). The authors propose that interactions
between dystrophin and pikachurin–Dg complex regulate the
adhesion required for apposition of bipolar cell dendritic tips to
the photoreceptor ribbon synapses by inducing a structural change
in the photoreceptor terminus or by attracting the postsynaptic
terminus through an unknown factor. More recently, using retinal
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photoreceptor-speciﬁc Dg knockout in mice, it was found that the
loss of Dg prevents the pikachurin accumulation on tips of
photoreceptor synapses. Furthermore, the overexpression of pika-
churin in cell cultures (HEK293 cells) induces the clustering of
α-Dg–pikachurin complex on the cell surface. These data suggest
that the pikachurin is required for the presynaptic accumulation of
Dg on the photoreceptor synaptic surface of retina, and conversely
that the Dg is required for pikachurin accumulation. They also
suggest that interactions of pikachurin with the Dg at photore-
ceptor cell surfaces are required for the formation of proper
photoreceptor ribbon synaptic structures (Omori et al., 2012). It
will be of interest now to determine whether the binding between
pikachurin and Dg is required for the pikachurin function and to
determine mechanisms by which the pikachurin regulates the
apposition of bipolar cell dendritic tips to photoreceptor-ribbon
synapses. This will provide clues to understand adhesive interac-
tions between ECM and Dg that are required for the formation and
function of synaptic structures underlying the retinal abnormal-
ities observed in muscular dystrophy patients.
In avian and Xenopus retina, the Dg protein is detectable on
lens vesicle, vitreal border of retina in the endfeet of neuroepithe-
lial progenitors and on cells fated to form the pigmented epithelial
layer. In Xenopus, morpholino-mediated loss of Dg function causes
the disruption of basal lamina layers and increases apoptosis at
early stages. Later in development, it display ocular malformations,
such as microphtalmia and retinal delayering with photoreceptors
and ganglion cells scattered throughout the retina or aggregated in
rosette-like structures (Lunardi et al., 2006). In Dg-deﬁcient
Zebraﬁsh embryos, cells within ganglion cell layers are loosely
packed with gaps therebetween. Also, the lens contains cells with
several inclusion bodies and the cornea is absent (Gupta et al.,
2011).
In the adult Drosophila brain, the Dg is detected in the medulla
and lamina. The Dg is also present in the retina. In the larval brain,
the Dg is expressed in neurons and glial cells. A high level of Dg is
detected in axons of photoreceptor sensory neurons, in the optic
stalk, and in glial cells in optic lobes (Shcherbata et al., 2007). The
overexpression of Dg in photoreceptors results in a small but
signiﬁcant increase in their size. Genetic and RNAi-induced per-
turbations of Dg cause abortive photoreceptor elongation during
differentiation that results in stunted photoreceptors in the adult.
The Dg does not affect neuronal commitment but is necessary to
regulate neuronal adhesion required for proper photoreceptor
axon adhesion and migration during differentiation (Shcherbata
et al., 2007; Zhan et al., 2010).
Together, these data show that Dg–ligand interactions are
required for the integrity of basement membranes in the brain,
cornea and retina and that disruption of this function results in
abnormal cell adhesion required for the proper embryonic devel-
opment of these tissues. They also show that the Dg is nestled in
an adhesome required for cell adhesion mechanisms leading
to neuroblast migration, axon guidance and ribbon synapse
formation.
Dystroglycan in cell signaling and shape
In addition to the above crucial roles at the plasma membrane,
the Dg also functions as a signal-transducing molecule. The α-Dg
receives inputs from extracellular laminins or other LG domain
containing ligands, which are transduced via the β-Dg to generate
signals inside cells. In vitro, cellular adhesion to ﬁbronectin, agrin
or laminin was shown to trigger the phosphorylation of the
tyrosine residue (Y892) within the β-Dg cytoplasmic domain that
is one of the residues involved in interactions with the WW
domain of dystrophin or utrophin (Sotgia et al., 2003). This
tyrosine is also involved in the binding of the SH3 domain of
Grb2, an adapter protein involved in signal transduction and
cytoskeleton organization, both in skeletal muscle and brain
(Moore and Winder, 2010). In bovine brain synaptosomes, the
β-Dg binds the FAK through the SH2 domain of Grb2 (Cavaldesi
et al., 1999). As a general mechanism, the phosphorylation of β-Dg
might modulate its interaction with dystrophin or utrophin,
functioning as a molecular switch between WW or SH3, and SH2
domains. The Dg was also thought to modulate the Mitogen-
activated-protein-kinase-Kinase/Extracellular signal-Regulated
Kinases (MEK/ERK) pathway according to two mechanisms. First,
α-Dg competes with α6β1 integrins for the binding with laminin,
reducing the ERK activity (Ferletta et al., 2003). Second, the Dg
sequesters speciﬁc components of the signaling cascade and
thereby limits their activity to deﬁne cellular compartment. Then,
in Cos-7 cells, the β-Dg interacts with MEK within membrane
rufﬂes, capturing it and preventing the phosphorylation of ERK
catalyzed by MEK (Spence et al., 2004a, 2004b). It has been also
shown that blocking the interaction of α-Dg with laminins results
in an increased activity of caspase-3, a known hallmark of
apoptosis, and an inhibition of the PI3K/Akt signaling pathway
that promotes cell survival (Datta et al., 1999).
An outside-in signaling is also highlighted in Xenopus prone-
phros, skin and notochord because the deletion of the Dg-
cytoplasmic domain does not prevent interactions between lami-
nin and cells that express the mutant protein, but abolishes the
downstream morphogenesis of these tissues (Bello et al., 2008;
Sirour et al., 2011; Buisson et al., in preparation). Furthermore,
point mutations in the Dg-cytoplasmic domain do not prevent
laminin/Dg bindings but lead to the disruption of the mediolateral
intercalation of cells required for notochord formation and/or
affect the cytoskeleton integrity required for the differentiation
of notochord cells (Buisson et al., in preparation).
Dg is also involved in the formation of actin-rich membrane
surface protrusions, such as microvilli-like structures of epithelial cells.
The β-Dg has been shown to bind the cytoskeletal adapter protein,
ezrin, and forms a complex with a RhoGEF (guanine nucleotide-
exchange factor), which may be responsible for activating Cdc42 in a
localized manner and thus causes the ﬁlopodia phenotype in ﬁbro-
blasts (Batchelor et al., 2007). Moreover, it has been shown that the Dg
interacts with vinculin by binding to the vinculin-binding protein,
vinexin. By this interaction, the Dg controls cell adhesion and spread-
ing in myoblast focal adhesion (Thompson et al., 2010).
Another argument, which suggests that laminin/Dg interac-
tions generate intracellular signaling in vivo, comes from the
analysis of skin development in Xenopus embryos. The Dg deple-
tion leads to the down regulation of the transcription factor P63, a
marker of differentiated epidermis. In addition, the inhibition or
activation of the Notch pathway prevents and promotes transcrip-
tion of X-dg suggesting that Dg acts as a key-signaling component
in the Notch pathway (Sirour et al., 2011).
All these data highlight the fact that following cell adhesion to
the laminin rich ECM via the Dg, the cytoplasmic domain of Dg
may assembles multiprotein complexes that relay signals coming
from ECM–cell interactions to regulate cytoskeletal assembly, cell
shape and intracellular signaling pathways.
Conclusions
In conclusion, there are many experimental arguments that
strengthen the idea that Dg and its extra- and intracellular partners
have all the functional characteristics of an adhesome providing
interactive interfaces between ECMs, the cellular scaffoldings and
signaling machineries. Throughout the embryonic development, it
acts to ensure both the adhesion of cells to matrices as well as the
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transduction of signals. It results that this adhesome is involved in
mechanisms of cell adhesion required for matrix organization, cell
polarity, cell shape, cell signaling and mechanical stability of tissues
at any time during embryonic development (Fig. 1). Interestingly,
functions of this adhesome seem to vary according to species, tissues,
organs, and especially during embryonic development. Although
substantial progress has been made toward dissecting the adhesive
function of Dg adhesome, many questions remain for the future. In
particular, how the integrin and Dg adhesomes work synergistically or
independently to regulate efﬁciently cell adhesive interactions with
ECMs during development? In addition to identifying new cytoplasmic
ligands, another major challenge is to elucidate how the Dg is linked to
pathways of cell communication, signal transduction and gene tran-
scription that contribute to each step of development. Answering this
question will certainly improve our understanding of how the Dg-
adhesome regulates the adhesion between cells and ECMs required for
embryonic developmental processes. The role of miRNAs is also a
signiﬁcant open question. The searches of miRNAs that targeted Dg
might reveal important information about the regulation of complex
molecular events involved in the patterning, maintenance, and turn-
over of this adhesome. This will be extremely important for a better
understanding of the Dg-adhesome function that contributes to cell-
matrix adhesion during development and its dysfunction that leads to
disorders of embryonic development.
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